75294 Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices 

Last name First name 

WENDEL ................... JENNIFER. 

WESLEY ................... KENYATA. 

WILLIAMS ................. CARLIS. 

WILLIAMS ................. RASHEED. 

WULFF ...................... KATHARINE. 

YARBOROUGH ........ LA MONTE. 

Michelle Monroe, 

Director, Executive Resources. 

[FR Doc. 2023–24207 Filed 11–1–23; 8:45 am] 

BILLING CODE 4151–17–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, NIDDK. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended for the review, discussion, 

and evaluation of individual grant 

applications conducted by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 19–20, 2024. 

Open: April 19, 2024, 10:00 a.m. to 10:20 

a.m. 

Agenda: Introductions and Overview. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Closed: April 19, 2024, 10:30 a.m. to 5:00 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual Investigators. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Michael W. Krause, Ph.D., 

Scientific Director, NIDDK, National Institute 

of Diabetes and Digestive and Kidney 

Diseases, National Institute of Health, 

Building 5, Room B104, Bethesda, MD 

20892–1818, (301) 402–4633, mwkrause@

helix.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 27, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–24139 Filed 11–1–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Molecular 

and Cellular Analysis Technologies. 

Date: December 14–15, 2023. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W608, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W608, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Survivorship Needs of Individuals Living 

with Advanced Cancer (R01). 

Date: January 11, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W108, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; IMAT 

Biospecimen Research. 

Date: January 11, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Rockville, Maryland 20850, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Technologies for Cancer Research. 

Date: January 25–26, 2024. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W608, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W608, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Transition Career Development Award and 

Institutional Research Training and 

Education Grants. 

Date: January 25, 2024. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Rockville, Maryland 20850, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

(P50) Review SEP–II. 

Date: February 1–2, 2024. 

Time: 9:30 a.m. to 5:30 p.m. 


khammond on DSKJM1Z7X2PROD with NOTICES